全文获取类型
收费全文 | 2796篇 |
免费 | 107篇 |
国内免费 | 31篇 |
专业分类
耳鼻咽喉 | 18篇 |
儿科学 | 32篇 |
妇产科学 | 60篇 |
基础医学 | 316篇 |
口腔科学 | 28篇 |
临床医学 | 318篇 |
内科学 | 733篇 |
皮肤病学 | 47篇 |
神经病学 | 263篇 |
特种医学 | 113篇 |
外科学 | 388篇 |
综合类 | 7篇 |
一般理论 | 2篇 |
预防医学 | 126篇 |
眼科学 | 13篇 |
药学 | 243篇 |
中国医学 | 2篇 |
肿瘤学 | 225篇 |
出版年
2024年 | 3篇 |
2023年 | 9篇 |
2022年 | 30篇 |
2021年 | 55篇 |
2020年 | 28篇 |
2019年 | 29篇 |
2018年 | 53篇 |
2017年 | 40篇 |
2016年 | 37篇 |
2015年 | 55篇 |
2014年 | 75篇 |
2013年 | 100篇 |
2012年 | 220篇 |
2011年 | 227篇 |
2010年 | 104篇 |
2009年 | 104篇 |
2008年 | 220篇 |
2007年 | 243篇 |
2006年 | 189篇 |
2005年 | 206篇 |
2004年 | 212篇 |
2003年 | 197篇 |
2002年 | 168篇 |
2001年 | 19篇 |
2000年 | 13篇 |
1999年 | 26篇 |
1998年 | 47篇 |
1997年 | 36篇 |
1996年 | 26篇 |
1995年 | 33篇 |
1994年 | 19篇 |
1993年 | 12篇 |
1992年 | 9篇 |
1991年 | 12篇 |
1990年 | 12篇 |
1989年 | 9篇 |
1988年 | 5篇 |
1987年 | 3篇 |
1986年 | 8篇 |
1985年 | 7篇 |
1984年 | 7篇 |
1983年 | 7篇 |
1982年 | 5篇 |
1981年 | 8篇 |
1978年 | 2篇 |
1977年 | 1篇 |
1968年 | 1篇 |
1967年 | 1篇 |
1966年 | 2篇 |
排序方式: 共有2934条查询结果,搜索用时 15 毫秒
41.
Daria Soroka Inès Li de la Sierra-Gallay Vincent Dubée Sébastien Triboulet Herman van Tilbeurgh Fabrice Compain Lluis Ballell David Barros Jean-Luc Mainardi Jean-Emmanuel Hugonnet Michel Arthur 《Antimicrobial agents and chemotherapy》2015,59(9):5714-5720
Combinations of β-lactams with clavulanate are currently being investigated for tuberculosis treatment. Since Mycobacterium tuberculosis produces a broad spectrum β-lactamase, BlaC, the success of this approach could be compromised by the emergence of clavulanate-resistant variants, as observed for inhibitor-resistant TEM variants in enterobacteria. Previous analyses based on site-directed mutagenesis of BlaC have led to the conclusion that this risk was limited. Here, we used a different approach based on determination of the crystal structure of β-lactamase BlaMAb of Mycobacterium abscessus, which efficiently hydrolyzes clavulanate. Comparison of BlaMAb and BlaC allowed for structure-assisted site-directed mutagenesis of BlaC and identification of the G132N substitution that was sufficient to switch the interaction of BlaC with clavulanate from irreversible inactivation to efficient hydrolysis. The substitution, which restored the canonical SDN motif (SDG→SDN), allowed for efficient hydrolysis of clavulanate, with a more than 104-fold increase in kcat (0.41 s−1), without affecting the hydrolysis of other β-lactams. Mass spectrometry revealed that acylation of BlaC and of its G132N variant by clavulanate follows similar paths, involving sequential formation of two acylenzymes. Decarboxylation of the first acylenzyme results in a stable secondary acylenzyme in BlaC, whereas hydrolysis occurs in the G132N variant. The SDN/SDG polymorphism defines two mycobacterial lineages comprising rapidly and slowly growing species, respectively. Together, these results suggest that the efficacy of β-lactam–clavulanate combinations may be limited by the emergence of resistance. β-Lactams active without clavulanate, such as faropenem, should be prioritized for the development of new therapies. 相似文献
42.
43.
Dessy C Saliez J Ghisdal P Daneau G Lobysheva II Frérart F Belge C Jnaoui K Noirhomme P Feron O Balligand JL 《Circulation》2005,112(8):1198-1205
44.
45.
Manetti M Allanore Y Saad M Fatini C Cohignac V Guiducci S Romano E Airó P Caramaschi P Tinazzi I Riccieri V Della Rossa A Abbate R Caporali R Cuomo G Valesini G Dieudé P Hachulla E Cracowski JL Tiev K Letenneur L Amouyel P Lambert JC Chiocchia G Martinez M Ibba-Manneschi L Matucci-Cerinic M 《Annals of the rheumatic diseases》2012,71(6):1034-1041
46.
Koumakis E Giraud M Dieudé P Cohignac V Cuomo G Airò P Hachulla E Matucci-Cerinic M Diot E Caramaschi P Mouthon L Riccieri V Cracowski JL Tiev KP Francès C Amoura Z Sibilia J Cosnes A Carpentier P Valentini G Manetti M Guiducci S Meyer O Kahan A Boileau C Chiocchia G Allanore Y 《Arthritis and rheumatism》2012,64(8):2746-2752
47.
Lioure B Béné MC Pigneux A Huynh A Chevallier P Fegueux N Blaise D Witz B Delain M Cornillon J Luquet I Blanchet O Cornillet-Lefebvre P Carré M Hunault M Larosa F Lamy T Randriamalala E Ojeda-Uribe M Berthou C Fornecker L Harousseau JL Bouscary D Ifrah N Cahn JY;GOELAMS 《Blood》2012,119(12):2943-2948
The LAM2001 phase 3 trial, involving 832 patients with acute myeloid leukemia (AML; median: 46 years) proposed HLA-identical sibling allograft HSCT for all patients with an identified donor. The trial compared reduced-intensity conditioning (RIC) for patients older than 50 years of age (N = 47) and myeloablative conditioning for younger patients (N = 117). BM HSCT was performed in the younger patients, while the older ones received a consolidation course, followed by peripheral blood allo-HSCT using RIC. The incidence of grade II-IV acute GVHD, was 51.9% (95% confidence interval [CI]: 42.1-61.8) and 11.3% (1.6-21.2) after myeloablative or RIC, respectively (P < .0001) and that of chronic GVHD 45.8% (95% CI: 34.8-56.7) and 41.7% (24.7-58.6; NS). Cumulative incidence of nonrelapse mortality at 108 months was 15.8% (95% CI: 9.8-23.2) for myeloablative, and 6.5% (0.2-16.2) for RIC (NS). CI of relapse at 108 months was 21.7% (95% CI: 13.9-28.6) and 28.6% (16.5-43.4; NS). Overall survival at 108 months was 63.4% (95% CI: 54.6-72.2) and 65.8% (52.2-72.2), respectively, after myeloablative or RIC (NS). RIC peripheral blood stem cell allo-HSCT is prospectively feasible for patients between the ages of 51 and 60 years without excess of relapse or nonrelapse mortality, and compares favorably with myeloablative marrow allo-HSCT proposed to younger patients. 相似文献
48.
Zarski JP Sturm N Guechot J Paris A Zafrani ES Asselah T Boisson RC Bosson JL Guyader D Renversez JC Bronowicki JP Gelineau MC Tran A Trocme C De Ledinghen V Lasnier E Poujol-Robert A Ziegler F Bourliere M Voitot H Larrey D Rosenthal-Allieri MA Fouchard Hubert I Bailly F Vaubourdolle M;ANRS HCEP Fibrostar Group 《Journal of hepatology》2012,56(1):55-62
49.
Joël Macoir Marion Fossard Jean-Luc Nespoulous Jean-François Demonet Anne-Catherine Bachoud-Lévi 《Neurocase》2013,19(4):358-376
Declarative memory is a long-term store for facts, concepts and words. Procedural memory subserves the learning and control of sensorimotor and cognitive skills, including the mental grammar. In this study, we report a single-case study of a mild aphasic patient who showed procedural deficits in the presence of preserved declarative memory abilities. We administered several experiments to explore rule application in morphology, syntax and number processing. Results partly support the differentiation between declarative and procedural memory. Moreover, the patient's performance varied according to the domain in which rules were to be applied, which underlines the need for more fine-grained distinctions in cognition between procedural rules. 相似文献
50.